This inventor holds 1 USPTO granted patent. Top assignee: S O 'Pharmachim'. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: The Innovations of Nikola G Alexandrov
Introduction
Nikola G Alexandrov is a notable inventor based in Sofia, Bulgaria. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative approach to antihypoxic drugs. His work focuses on developing treatments that can effectively combat hypoxia and related conditions.
Latest Patents
Nikola G Alexandrov holds a patent for an antihypoxic drug and method of its application. This drug, which combines piracetam and orotic acid or their pharmaceutically tolerable salts, is designed to provide both verebroprotective and hepatoprotective effects. The formulation is administered in varying daily doses, ranging from 0.150 to 50 g, depending on the severity of the condition being treated. Clinical data supports the synergistic effect of this combination, demonstrating its efficacy in antihypoxic action. The drug can be administered both orally and parenterally, making it versatile for treating acute and chronic diseases as well as exogenic intoxications.
Career Highlights
Nikola G Alexandrov is associated with S O Pharmachim, where he continues to innovate in the pharmaceutical sector. His dedication to research and development has led to advancements in drug formulations that address critical health issues. His work is characterized by a commitment to improving patient outcomes through effective medication.
Collaborations
Nikola collaborates with talented professionals in his field, including Ani I Genova and Milka P Nikolova. These partnerships enhance the research and development process, allowing for a more comprehensive approach to innovation in pharmaceuticals.
Conclusion
Nikola G Alexandrov's contributions to the field of antihypoxic drugs exemplify the impact of innovative thinking in medicine. His patent reflects a significant advancement in treatment options for patients facing hypoxia and related conditions. Through his work, he continues to pave the way for future developments in pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile